Alex Karnal, Co-Founder and CIO of Braidwell, joins Bloomberg's Anna Edwards on "The Pulse" to discuss the company's approach to investing in transformative medicines, technologies, and medical devices by integrating artificial intelligence. (Source: Bloomberg)
Alex Karnal, Co-Founder and CIO of Braidwell, joins Bloomberg's Anna Edwards on "The Pulse" to discuss the company's approach to investing in transformative medicines, technologies, and medical devices by integrating artificial intelligence. (Source: Bloomberg)
<iframe src="https://statesidedaily.com/embed/cluster/ca265d962656600b287c9d735b5d08d910beaee3" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Braidwell's Karnal on How AI Can Impact Bioscience"></iframe>
